Supplement 

Management of Retinal Vascular Diseases: A Patient-Centric Approach

This supplement was supported by Novartis Pharmaceuticals Limited (UK). Novartis Pharmaceuticals Limited (UK) has had the opportunity to comment on the medical content and accuracy of the article; however, final editorial content resides with the author and the journal. The author thanks Sue Harris from ApotheCom, who provided medical writing support on behalf of Novartis Pharmaceuticals.

Review